Alternative to LRRK2-IN-1 for Pharmacological Studies of Parkinson's Disease.

Koshibu, Kyoko

Alternative to LRRK2-IN-1 for Pharmacological Studies of Parkinson's Disease. [electronic resource] - Pharmacology 2015 - 240-7 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1423-0313

10.1159/000439136 doi


Animals
Benzodiazepinones--adverse effects
Blood-Brain Barrier--drug effects
Caco-2 Cells
Cell Survival--drug effects
Drug Discovery--methods
Drug Stability
Hep G2 Cells
Hepatocytes--drug effects
Humans
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
Male
Metabolic Clearance Rate
Microsomes, Liver--drug effects
Parkinson Disease--drug therapy
Protein Kinase Inhibitors--adverse effects
Protein Serine-Threonine Kinases--antagonists & inhibitors
Pyrimidines--adverse effects
Rats, Sprague-Dawley
Substrate Specificity
Tissue Distribution